Anchiano Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ANCN and buy or sell other stocks, ETFs, and their options commission-free!About ANCN
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
CEOAdi Mor, PhD
CEOAdi Mor, PhD
Employees16
Employees16
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2011
Founded2011
Employees16
Employees16
ANCN Key Statistics
Market cap20.99M
Market cap20.99M
Price-Earnings ratio-1.02
Price-Earnings ratio-1.02
Dividend yield—
Dividend yield—
Average volume109.40K
Average volume109.40K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.84
52 Week high$9.84
52 Week low$1.73
52 Week low$1.73
Stock Snapshot
The current Anchiano Therapeutics(ANCN) stock price is $3.41, with a market capitalization of 20.99M. The stock trades at a price-to-earnings (P/E) ratio of -1.02.
During the trading day, Anchiano Therapeutics(ANCN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Anchiano Therapeutics(ANCN) stock has reached 0, versus its average volume of 109.4K.
The stock's 52-week range extends from a low of $1.73 to a high of $9.84.
The stock's 52-week range extends from a low of $1.73 to a high of $9.84.